| Literature DB >> 35734388 |
Inna C De Leon1, JennaLynn Philipps1, Marina Yoegel1,2,3, Joseph Byrnes2, Jordan S Kase1,3.
Abstract
The sudden transition to virtual therapeutic services during the COVID-19 pandemic provided a unique opportunity to explore telehealth as a platform for delivering early intervention (EI) services. Through retrospective chart review of 93 children, we collected the following data: demographics, diagnosed conditions, therapy type, service format, and provider-reported participant goal achievement (1=no progress, 2=little progress, 3=moderate progress, 4=great deal of progress, 5=outcome achieved) over a six-month period before and after transitioning to telehealth. Pre- and post-transition progress scores were compared using the Wilcoxon signed-rank test. Results demonstrated maintained progress among children who transitioned from in-person to virtual services for similar therapy types. Children receiving speech therapy in-person and virtually demonstrated increased achievement (3.00 vs 3.33; p=0.032). Participants receiving a particular therapy post-transition but not in-person attained similar achievement as those who received the same therapy only in-person. Our research suggests that teletherapy may be a viable option for delivering EI services.Entities:
Keywords: COVID-19; Early intervention; Telehealth
Year: 2022 PMID: 35734388 PMCID: PMC9186834 DOI: 10.5195/ijt.2022.6450
Source DB: PubMed Journal: Int J Telerehabil ISSN: 1945-2020
EI Participant Demographic Information
| Age in Months on 3/18/2020 (mean ± SD) | 23 ± 8 | |
| Time between Program Enrollment and 3/18/2020 in Months (mean ± SD) | −8 ± 8 | |
| Gender n (%) | Male | 58 (64%) |
| Female | 32 (36%) | |
| Race/Ethnicity n (%) | White or Caucasian | 70 (75.3%) |
| Black or African American | 5 (5.4%) | |
| Asian | 3 (3.2%) | |
| Hispanic or Latino | 12 (12.9%) | |
| Unavailable | 3 (3.2%) | |
| Insurance Type n (%) | Non-Medicaid | 67 (72%) |
| Any Medicaid and Non-Medicaid | 14 (16.2%) | |
| Declined to Answer | 7 (7.5%) | |
| Unavailable | 4 (4.3%) | |
EI Participant Clinical Information
| Diagnosed Condition | Number of Participants (%) |
|---|---|
| Dyspraxia | 43 (46.2%) |
| Mixed Receptive-Expressive Language Disorder | 36 (38.7%) |
| Delayed Milestone in Childhood | 25 (26.9%) |
| Generalized Muscle Weakness | 20 (21.5%) |
| Feeding Difficulties | 10 (10.8%) |
| Autistic Disorder | 10 (10.8%) |
| Unspecified Lack of Coordination | 9 (9.7%) |
| Hearing Loss | 3 (3.2%) |
| Torticollis | 3 (3.2%) |
| Extremely Low Birthweight | 2 (2.2%) |
| Down Syndrome | 1 (1.1%) |
| Angelman Syndrome | 1 (1.1%) |
| Obstructive Hydrocephalus | 1 (1.1%) |
Pre- and Post-Transition Period EI Services Participation (Total Subjects n=93)
| Therapy Type (n) | In-Person Therapy Only n (%) | Teletherapy Only n (%) | In-Person Transition to Teletherapy n (%) |
|---|---|---|---|
|
| 14 (30.4%) | 7 (15.3%) | 25 (54.3%) |
|
| 13 (35.2%) | 9 (24.3%) | 15 (40.5%) |
|
| 15 (25.4%) | 23 (39.0%) | 21 (35.6%) |
|
| 10 (31.2%) | 10 (31.2%) | 12 (37.6%) |
Comparison of Progress Scores for Participants Receiving the Same Therapy Type Both In-Person Therapy and Via Teletherapy
| Therapy Type | In-Person Therapy Progress Score Median (Range) | Teletherapy Progress Score Median (Range) | P-value | In-Person Therapy Total Goals Median (Range) | Teletherapy Total Goals Median (Range) | P-value |
|---|---|---|---|---|---|---|
|
| 3.67 (2.00–5.00) | 4.00 (1.67–5.00) | 0.676 | 2 (2–4) | 2 (1–5) | 0.574 |
|
| 3.00 (2.00–4.00) | 3.00 (1.00–4.00) | 0.889 | 2 (2–3) | 2 (2–3) | 0.914 |
|
| 3.00 (1.00–4.67) | 3.33 (2.00–4.67) | 0.032 | 3 (2–5) | 2 (1–5) | 0.049 |
|
| 3.00 (1.33–4.33) | 3.00 (2.00–4.33) | 0.326 | 2 (2–4) | 3 (3–5) | 0.220 |
Comparison of Progress Scores for Participants Receiving Differing Therapy Types In-Person versus Teletherapy
| Therapy Type | In-Person Therapy Progress Score Median (Range) | Teletherapy Progress Score Median (Range) | P-value | In-Person Therapy Total Goals Median (Range) | Teletherapy Total Goals Median (Range) | P-value |
|---|---|---|---|---|---|---|
|
| 3.00 (2.00–5.00) | 3.00 (1.60–4.60) | 0.751 | 3 (1–4) | 3 (1–6) | 0.853 |
|
| 3.00 (2.00–4.00) | 2.50 (2.00–4.33) | 0.435 | 3 (2–3) | 3 (2–6) | 0.857 |
|
| 3.00 (2.00–4.67) | 3.00 (1.33–5.00) | 0.359 | 3 (2–3) | 3 (1–5) | 0.899 |
|
| 2.45 (1.00–3.67) | 2.59 (1.00–4.00) | 0.849 | 3 (1–5) | 3 (3–6) | 0.257 |